精神分裂症非多巴胺治疗的进展:管道发展的系统审查
Yuki Komatsu1,2, Moe Takehara3, Xenia Hart1,4
1Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan.
Pharmacopsychiatry
|May 6, 2024
概括
新的非多巴胺类药物对精神分裂症治疗有希望. 几种化合物在临床试验中有效向积极症状,消极症状或认知缺陷.
科学领域:
- 精神病学是一个精神病学.
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 针对多巴胺的常规抗精神病药对相当一部分精神分裂症患者无效.
- 对于治疗精神分裂症的新型非多巴胺激素治疗药物有着迫切的需要.
研究的目的:
- 识别和评估在治疗精神分裂症方面表现出有效性的非多巴胺化合物.
- 评估新药在症状特异性治疗策略中的潜力.
主要方法:
- 从美国和欧盟注册处系统搜索已完成的II期和III期临床试验.
- 在初级结果测量中识别出显示明显优于安慰剂的化合物.
- 通过PubMed和新闻稿收集附带信息.
主要成果:
- 确定了16种化合物,作为单一疗法或附加疗法进行了研究.
- 乌罗塔隆特,沙诺梅林/托斯皮化物,瓦比卡塞林,比托珀丁,雌激醇,大麻醇,里莫纳班特和D-赛林在积极症状方面表现出有效性.
- 罗卢佩里和皮马万塞林对负面症状有效;恩森尼克林,热热,孕,托尔卡,BI 425809,和瓦拉环改善了认知功能.
结论:
- 具有非多巴胺作用机制的新型化合物为精神分裂症提供了潜在的治疗策略.
- 这些药物可以提供症状特异性治疗,解决当前抗精神病药物的局限性.
相关概念视频
Drug Therapy
42
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
42
Psychosis: Goals of Pharmacotherapy
123
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
123
Psychosis and Antipsychotic Drugs: Overview
242
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
242
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
592
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
592
Antipsychotic Drugs: Therapeutic Uses and Side Effects
175
Antipsychotic drugs primarily block dopamine and serotonin receptors and cholinergic, adrenergic, and histaminergic receptors, thereby reducing hallucinations and delusions in conditions like schizophrenia. However, they can trigger unwanted extrapyramidal effects such as dystonias, Parkinson-like symptoms, and tardive dyskinesia.
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
175
Antidepressant Drugs: MAOIs and Other Agents
226
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
226


